Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/7810
Full metadata record
DC FieldValueLanguage
dc.contributor.authorJuwita, Dian Ayu-
dc.contributor.authorRachmaini, Fitri-
dc.contributor.authorAlmahdy-
dc.contributor.authorAbdillah, Rahmad-
dc.contributor.authorWati, Yolanda Mayestika-
dc.date.accessioned2024-11-11T07:25:26Z-
dc.date.available2024-11-11T07:25:26Z-
dc.date.issued2022-07-
dc.identifier.issn2088 4559-
dc.identifier.urihttp://localhost:8080/xmlui/handle/123456789/7810-
dc.description.abstractChronic renal disease is significantly increased by hypertension. Controlling blood pressure is critical in hypertensive individuals. Patients who have good blood pressure (BP) control can reduce morbidity and mortality. This study aimed to compare blood pressure reduction of candesartanamlodipine with the candesartan-furosemide combination in hypertensive patients with chronic renal disease. The study was conducted by a cohort study design. Retrieval of medical record data was carried out prospectively during the period February-April 2019. The blood pressure reduction was assessed by changes in mean systolic and mean diastolic blood pressure and mean diastolic blood pressure and was analyzed statistically with the SPSS program. A total of 54 patients met the inclusion criteria, consisting of 27 patients receiving candesartan-amlodipine combination and 27 patients receiving candesartan-furosemide combination therapy. The results of the sociodemographic characteristics patients were male 30 patients (55.6%), age 56-65 years 24 patients (44.4%), senior high school education level 31 patients (57.4%). Candesartan-amlodipine and candesartan-furosemide combinations both decreased blood pressure in patients. However, the result of the statistical analysis revealed that there was no significant difference in blood pressure decline. (p> 0.05) between the two combinations.en_US
dc.language.isoen_USen_US
dc.publisherPharmacianaen_US
dc.subjectblood pressureen_US
dc.subjectcandesartanen_US
dc.subjectamlodipineen_US
dc.subjectfurosemideen_US
dc.subjecthypertensionen_US
dc.subjectCKDen_US
dc.titleThe comparison between combination of candesartan-amlodipine and candesartan-furosemide on blood pressure in hypertensive patients with chronic kidney diseaseen_US
dc.typeArticleen_US
Appears in Collections:VOL 12 NO 2 2022

Files in This Item:
File Description SizeFormat 
218-226.pdf435.73 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.